SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

60 Degrees Pharmaceuticals Reports Improvement in All Five Completed Babesiosis Study Patients

The company reported clinical improvement in all five patients who completed its babesiosis study.

SXTP

Related stories